Description
Recombinant monoclonal antibody to CD8. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 51.1. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG2b format, created for improved compatibility with existing reagents, assays and techniques.
Target
CD8
Target Alias Names
CD8a, T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression